Pedro Brites

Dr. Pedro Brites


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2004 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
PBPedro Brites
Pedro Brites
HWHans R Waterham
Hans R Waterham
RWRonald J.A Wanders
Ronald J.A Wanders

1 April 1997 in Nature Genetics
Verified
Journal Article
Closed access
AMAlison M. Motley
Alison M. Motley
EHEwald H. Hettema
Ewald H. Hettema
EHEveline M. Hogenhout
Eveline M. Hogenhout
PBPedro Brites
Pedro Brites
AAAnneloor L.M.A. Ten Asbroek
Anneloor L.M.A. Ten Asbroek
BDBen Distel
Ben Distel

1 March 2010 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
RWRonald J. A. Wanders
Ronald J. A. Wanders
SFSacha Ferdinandusse
Sacha Ferdinandusse
PBPedro Brites
Pedro Brites
SKStephan Kemp
Stephan Kemp

1 February 2003 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
DBDaan M. van Den Brink
Daan M. van Den Brink
PBPedro Brites
Pedro Brites
JHJanet Haasjes
Janet Haasjes
AWAnthony S. Wierzbicki
Anthony S. Wierzbicki
JMJohn Mitchell
John Mitchell
JWJ.A. Ronald Wanders
J.A. Ronald Wanders

24 April 2014 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
TSTiago Ferreira da Silva
Tiago Ferreira da Silva
JEJessica Eira
Jessica Eira
ALAndré T. Lopes
André T. Lopes
AMAna R. Malheiro
Ana R. Malheiro
VSVera Sousa
Vera Sousa
PBPedro Brites
Pedro Brites
Rhizomelic chondrodysplasia punctata (RCDP) is a developmental disorder characterized by hypotonia, cataracts, abnormal ossification, impaired motor development, and intellectual disability. The underlying etiology of RCDP is a deficiency in the biosynthesis of ether phospholipids, of which plasmalogens are the most abundant form in nervous tissue and myelin; however, the role of plasmalogens in the peripheral nervous system is poorly defined. Here, we used mouse models of RCDP and analyzed the consequence of plasmalogen deficiency in peripheral nerves. We determined that plasmalogens are crucial for Schwann cell development and differentiation and that plasmalogen defects impaired radial sorting, myelination, and myelin structure. Plasmalogen insufficiency resulted in defective protein kinase B (AKT) phosphorylation and subsequent signaling, causing overt activation of glycogen synthase kinase 3β (GSK3β) in nerves of mutant mice. Treatment with GSK3β inhibitors, lithium, or 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) restored Schwann cell defects, effectively bypassing plasmalogen deficiency. Our results demonstrate the requirement of plasmalogens for the correct and timely differentiation of Schwann cells and for the process of myelination. In addition, these studies identify a mechanism by which the lack of a membrane phospholipid causes neuropathology, implicating plasmalogens as regulators of membrane and cell signaling.

6 December 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PBPedro Brites
Pedro Brites
AFAna Sofia Ferreira
Ana Sofia Ferreira
TSTiago Ferreira da Silva
Tiago Ferreira da Silva
VSVera F. Sousa
Vera F. Sousa
AMAna R. Malheiro
Ana R. Malheiro
RWRonald J. A. Wanders
Ronald J. A. Wanders
A deficiency of plasmalogens, caused by impaired peroxisomal metabolism affects normal development and multiple organs in adulthood. Treatment options aimed at restoring plasmalogen levels may be relevant for the therapy of peroxisomal and non-peroxisomal disorders. In this study we determined the in vivo efficacy of an alkyl glycerol (AG), namely, 1-O-octadecyl-rac-glycerol, as a therapeutic agent for defects in plasmalogen synthesis. To achieve this, Pex7 knockout mice, a mouse model for Rhizomelic Chondrodysplasia Punctata type 1 characterized by the absence of plasmalogens, and WT mice were fed a control diet or a diet containing 2% alkyl-glycerol. Plasmalogen levels were measured in target organs and the biochemical data were correlated with the histological analysis of affected organs. Plasmalogen levels in all peripheral tissues of Pex7 KO mice fed the AG diet for 2 months normalized to the levels of AG fed WT mice. In nervous tissues of Pex7 KO mice fed the AG-diet, plasmalogen levels were significantly increased compared to control fed KO mice. Histological analysis of target organs revealed that the AG-diet was able to stop the progression of the pathology in testis, adipose tissue and the Harderian gland. Interestingly, the latter tissues are characterized by the presence of lipid droplets which were absent or reduced in size and number when ether-phospholipids are lacking, but which can be restored with the AAG treatment. Furthermore, nerve conduction in peripheral nerves was improved. When given prior to the occurrence of major pathological changes, the AG-diet prevented or ameliorated the pathology observed in Pex7 KO mice depending on the degree of plasmalogen restoration. This study provides evidence of the beneficial effects of treating a plasmalogen deficiency with alkyl-glycerol.